Chengsheng Wu

1.0k total citations
25 papers, 837 citations indexed

About

Chengsheng Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chengsheng Wu has authored 25 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Immunology. Recurrent topics in Chengsheng Wu's work include Cancer Cells and Metastasis (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer Genomics and Diagnostics (3 papers). Chengsheng Wu is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer Genomics and Diagnostics (3 papers). Chengsheng Wu collaborates with scholars based in Canada, China and United States. Chengsheng Wu's co-authors include Raymond Lai, Abdulraheem Alshareef, Nidhi Gupta, Eivind Heggernes Ask, ZhengMing Wu, Robert Blum, Zhu Huang, Karl‐Johan Malmberg, Dan S. Kaufman and Davide Bernareggi and has published in prestigious journals such as Blood, Nature Cell Biology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chengsheng Wu

24 papers receiving 824 citations

Peers

Chengsheng Wu

ONCOL

IMMUN

PFM

Benoît Thibault France

Vanessa Baeriswyl Switzerland

Angelina I. Londoño-Joshi United States

Alice Turdo Italy

Johanna Tuomela Finland

Yanjie He China

Brian Koss United States

Mario A. Shields United States

Alessio Biagioni Italy

Hallvard Haugen Norway

Benoît Thibault France

Chengsheng Wu

409 ×0.9

312 ×0.9

ONCOL

160 ×0.7

IMMUN

185 ×1.1

63 ×0.9

PFM

Citations per year, relative to Chengsheng Wu Chengsheng Wu (= 1×) peers Benoît Thibault

Countries citing papers authored by Chengsheng Wu

Since Specialization

Citations

This map shows the geographic impact of Chengsheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengsheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengsheng Wu more than expected).

Fields of papers citing papers by Chengsheng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengsheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengsheng Wu. The network helps show where Chengsheng Wu may publish in the future.

Co-authorship network of co-authors of Chengsheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengsheng Wu. A scholar is included among the top collaborators of Chengsheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengsheng Wu. Chengsheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ge, et al.. (2025). Permethrin Stimulates Fat Accumulation via Regulating Gut Microbiota and Its Metabolites in Mice. Journal of Agricultural and Food Chemistry. 73(34). 21352–21362.

Wu, Chengsheng, Sara M. Weis, & David A. Cheresh. (2023). Tumor-initiating cells establish a niche to overcome isolation stress. Trends in Cell Biology. 34(5). 380–387. 9 indexed citations

Wu, Chengsheng, Taha Rakhshandehroo, Hiromi I. Wettersten, et al.. (2023). Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation. Nature Cell Biology. 25(2). 309–322. 23 indexed citations

Wu, Chengsheng, Sara M. Weis, & David A. Cheresh. (2023). Upregulation of fibronectin and its integrin receptors – an adaptation to isolation stress that facilitates tumor initiation. Journal of Cell Science. 136(20). 7 indexed citations

Wu, Chengsheng, et al.. (2020). Feature Extraction of Cultural Gene Image Based on PCA Method. 2. 860–863. 4 indexed citations

Huang, Zhu, Robert Blum, Davide Bernareggi, et al.. (2020). Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell stem cell. 27(2). 224–237.e6. 233 indexed citations

Huang, Zhu, Robert Blum, Davide Bernareggi, et al.. (2020). Metabolic Reprograming Due to Deletion of <i>CISH</i> in Human Natural Killer Cells Promotes <i>in vivo</i> Persistence and Enhances Anti-Tumor Activity. SSRN Electronic Journal. 1 indexed citations

Vakili, Mohammad Reza, et al.. (2019). Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma. Cancers. 11(2). 248–248. 31 indexed citations

Gupta, Nidhi, Chengsheng Wu, Abdulraheem Alshareef, et al.. (2018). Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers. 10(2). 41–41. 12 indexed citations

10.

Wu, Chengsheng, et al.. (2018). Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma. BMC Cancer. 18(1). 361–361. 24 indexed citations

11.

Gupta, Nidhi, Karen Jung, Chengsheng Wu, et al.. (2017). High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer. Oncotarget. 8(17). 28101–28115. 23 indexed citations

12.

Alshareef, Abdulraheem, et al.. (2017). High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma. Scientific Reports. 7(1). 16863–16863. 8 indexed citations

13.

Alshareef, Abdulraheem, Haifeng Zhang, Chengsheng Wu, et al.. (2016). The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers. Scientific Reports. 6(1). 33710–33710. 36 indexed citations

14.

Wu, Chengsheng, Haifeng Zhang, Nidhi Gupta, et al.. (2016). A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. Journal of Hematology & Oncology. 9(1). 120–120. 27 indexed citations

15.

Zhang, Haifeng, Abdulraheem Alshareef, Chengsheng Wu, et al.. (2016). miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma. Carcinogenesis. 37(9). 858–869. 33 indexed citations

16.

Zhang, Hai-Feng, Ye Chen, Chengsheng Wu, et al.. (2015). The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 22(3). 691–703. 45 indexed citations

17.

Molavi, Ommoleila, Nasser Samadi, Chengsheng Wu, Afsaneh Lavasanifar, & Raymond Lai. (2015). Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma. Leukemia & lymphoma. 57(5). 1–9. 16 indexed citations

18.

Ye, Xiaoxia, Fang Wu, Chengsheng Wu, et al.. (2013). β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells. Cellular Signalling. 26(3). 492–501. 27 indexed citations

19.

Liu, Yushan, Chengsheng Wu, Jinyu Wang, Wei Mo, & Min Yu. (2013). Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris. Applied Microbiology and Biotechnology. 97(24). 10349–10358. 21 indexed citations

20.

Wu, Fang, Xiaoxia Ye, Peng Wang, et al.. (2013). Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity. BMC Cancer. 13(1). 317–317. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact